A lot of the frustration I’m seeing seems to come from two places: one, the slow pace of tangible newsflow and two, the lingering idea that management should have reinvested Mt Marion proceeds more directly into another lithium-producing asset. That’s understandable. It’s easy to look at where the broader lithium sector went and assume Neometals missed the boat. But the strategy here was never about being another spodumene developer.
What often gets overlooked is that NMT has consistently pursued high-margin, capital-light opportunities built around IP, licensing, and partnerships. Primobius, in particular, is not theoretical. It’s already operating. The Mercedes validation was a key credibility step and the relationship with Stelco is an opportunity that most junior companies would never have a chance at.
Where the company does fall short and this is where most criticism is fair - is timing. Milestones have slipped. The market is tired of being told something is around the corner. At this stage, execution matters more than potential. That’s the difference between value being realised or just conceptual.That said, NMT is still one of the few junior companies in this space with cash in the bank, real partnerships, and zero debt. If they deliver on even one of the three verticals, the upside is significant. This is not a trade based on drilling results or macro speculation. It’s a longer-cycle bet on commercialisation and revenue. If you're aligned with that timeframe, it still has merit.
IMO
GLTAH
Add to My Watchlist
What is My Watchlist?
